Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company committed to bringing finite and curative therapies to the 270 million people living with hepatitis B virus (HBV) worldwide. A pioneer in the development of a new class of potent, oral core inhibitor drug candidates, Assembly Bio’s approach aims to break the complex viral replication cycle of HBV to free patients from a lifetime of therapy. Assembly Bio’s strategy toward cure includes a leading portfolio of more potent, next-generation core inhibitors, proof-of-concept combination studies and a research program focused on the discovery of novel HBV targets. 

Biotechnology

Assembly Biosciences

Assembly Biosciences' headquarters in San Francisco, CA, United States

The Human Resources Team at Assembly Biosciences is responsible for managing and developing the company’s most valuable asset: its employees. This includes talent acquisition, organizational development, employee relations, performance management, and ensuring a positive workplace culture that aligns with the company’s mission to develop curative therapies for hepatitis B.

Human Resources Team

The Directors and Senior Directors Team at Assembly Biosciences is responsible for overseeing strategic initiatives and driving key projects across various domains, including drug development, discovery biology, medicinal chemistry, corporate development, financial planning, and clinical operations. This team ensures cohesive operational execution and leadership within the company, towards advancing curative therapies for hepatitis B. They play a pivotal role in fostering innovation, maintaining regulatory compliance, and guiding the company's clinical and research programs.

Directors and Senior Directors Team

The Scientific Team at Assembly Biosciences is responsible for the discovery, development, and advancement of innovative core inhibitor drug candidates aimed at curing hepatitis B virus (HBV). This team of experts conducts cutting-edge research on HBV mechanisms, designs proof-of-concept studies, and identifies novel therapeutic targets to disrupt the viral replication cycle, thereby contributing to the company's mission of providing finite and curative HBV therapies.

Scientific Team

The Leadership Team at Assembly Biosciences is responsible for setting the strategic direction and vision of the company, guiding its clinical and operational initiatives to develop curative therapies for hepatitis B. Comprising key executives with expertise in science, operations, and human resources, this team ensures effective decision-making, fosters innovation in drug development, and oversees the company's growth and performance in the biotechnology sector.

Leadership Team

The Finance and Accounting team at Assembly Biosciences is responsible for managing the company's financial health and reporting. This includes overseeing financial planning and analysis, accounting practices, treasury functions, and ensuring compliance with financial regulations. The team works to provide accurate financial data and strategic insights to support the company's mission of developing curative therapies for hepatitis B.

Finance and Accounting

This department focuses on the integration of biology, computer science, and information technology to analyze complex biological data.

Bioinformatics Department

This department focuses on advancing clinical pharmacology and preclinical research efforts to support drug development.

��

People (3)

Jobs (0)

Other teams

Directors and Senior Directors Team

Scientific Team

Leadership Team

Finance and Accounting

Bioinformatics Department

Clinical Research and Development

��������

People (3)

Jobs (0)

Other teams

Directors and Senior Directors Team

Scientific Team

Leadership Team

Finance and Accounting

Bioinformatics Department

Clinical Research and Development

��